In other countries
The same active substances on other registers, the same brand first.
- AvonexCanada · 30 MCG / 0.5 ML · Solution · Biogen Canada INCSame brand
- AvonexCanada · 60 MCG / ML · Powder For Solution · Biogen Canada INCSame brand
- AVONEX 30 microgramos/0,5 ml SOLUCION INYECTABLE EN PLUMA PRECARGADASpain · 30 µg · solución inyectable en pluma precargada · Biogen Netherlands B.V.Same brand
- AVONEX 30 microgramos/0,5 ml SOLUCION INYECTABLESpain · 0,3 µg · solución inyectable en jeringa precargada · Biogen Netherlands B.V.Same brand
- AvonexEuropean Union · Biogen Netherlands B.V.Same brand
- AvonexCroatiaSame brand
- AvonexItaly · Soluzione iniettabile · Biogen Netherlands BVSame brand
- AVONEX 30 microgram/0,5 ml, oplossing voor injectieNetherlands · Oplossing voor injectie · Biogen Netherlands B.V.Same brand
- AVONEX 30 microgram/0,5 ml oplossing voor injectie, in voorgevulde penNetherlands · Oplossing voor injectie · Biogen Netherlands B.V.Same brand
- AVONEX 30micrograme/0.5mlRomania · 30micrograme/0.5ml · sol. inj. in stilou injector (pen) preumplut · Biogen Idec LimitedSame brand
- AVONEX 30µg/0,5ml PENRomania · 30µg/0,5ml · sol inj. in stilou injector (pen) preumplut · Biogen Netherlands B.V.Same brand
- Avonex®Serbia · 30mcg/0.5mL · rastvor za injekciju u napunjenom injekcionom špricu · Medis Pharma D.O.O. BeogradSame brand
- Avonex®Serbia · 30mcg/0.5mL · rastvor za injekciju u napunjenom injekcionom špricu · Medis Pharma D.O.O. BeogradSame brand
- AVONEX 30 mcg/0.5 ml pre-filled penSaudi Arabia · Vetter Pharma-Fertigung, GMBH & Co. KGSame brand
- Avonex 30MCG Lyophilized Powder for InjSaudi Arabia · Biogen Idec Denmark Manufacturing APSSame brand
- Avonex 30MCG Lyophilized Powder for InjSaudi Arabia · Biogen Idec Denmark Manufacturing APSSame brand
- REBIF 44 micrograme/0.5 mlRomania · 44micrograme/0,5ml · sol inj. in cartus · Merck Europe B.V.Same strength and form
- Rebif®Serbia · 44mcg/0.5mL · rastvor za injekciju u ulošku · Merck D.O.O. BeogradSame strength and form
- Rebif Solution for Injection in Cartridge 22mcg/0.5mlSingapore · 22mcg/0.5ml · injection, solution · Merck Pte. LTD.Same strength and form
- Rebif Solution for Injection in Cartridge 44mcg/0.5mlSingapore · 44mcg/0.5ml · injection, solution · Merck Pte. LTD.Same strength and form
- Betaferon 250 Microgramos/ML Polvo y Disolvente Para Solucion InyectableSpain · 250 µg · polvo y disolvente para solución inyectable · Bayer AgSame form
- BetaferonItaly · Polvere e solvente per soluzione iniettabile · Bayer AGSame form
- RebifItaly · Soluzione iniettabile · Merck Europe B.V.Same form
- Betaferon, poeder en oplosmiddel voor oplossing voor injectieNetherlands · Poeder en oplosmiddel voor oplossing voor injectie · Bayer AGSame form
- AnyNew Zealand · Inj 8 million iu per ml, 1 ml vialSame form
- BetaferonNew Zealand · Inj 8 million iu per 1 mlSame form
- RebifCanada · 44 MCG / 0.5 ML · Solution · Emd Serono, A Division of Emd INC., CanadaSame substance
- BetaferonEuropean Union · Bayer AGSame substance
- RebifEuropean Union · Merck Europe B.V.Same substance
- BetaferonCroatiaSame substance
- RebifCroatiaSame substance
- Rebif 22 MicrogramsTaiwan · 注射劑 · 臺灣默克股份有限公司Same substance
- Rebif 44 MicrogramsTaiwan · 注射劑 · 臺灣默克股份有限公司Same substance
- Rebif solution for injection 132 microgramsTaiwan · 注射劑 · 臺灣默克股份有限公司Same substance
Documents
The official texts, at the regulator.
Sources and licences
Compiled by Prognia from the public register below; the register’s text is the official one.
U.S. Food and Drug Administration
FDA Purple Book, September 2026 release; acquired 2026-10-10T15:29:54.330165+00:00; exact source fields retained with source-key projections.
Licence: FDA-created structured factual administrative metadata; public-domain policy with third-party exceptions · Added 11 Oct 2026
Report an error or request removalCorrections from the holder or the register are welcome.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Active substance
- Interferon beta-1a
- Strength
- 30MCG/0.5ML
- Dosage form
- Injection
- Route
- Intramuscular
- Register
- United States (FDA)
- Status
- Marketed
- Status in the register
- Licensed / Rx
- Authorised
- 28 May 2003
- Registration
- BLA 103628
- Marketing authorisation holder
- Biogen Inc.
- Procedure
- 351(a)
- Supply
- Rx